Ontology highlight
ABSTRACT: Background
Offering ovarian function and/or fertility preservation strategies in premenopausal women with newly diagnosed breast cancer candidates to undergo chemotherapy is standard of care. However, few data are available on uptake and main reasons for refusing these options.Methods
The PREFER study (NCT02895165) is an observational, prospective study enrolling premenopausal women with early breast cancer, aged between 18 and 45 years, candidates to receive (neo)adjuvant chemotherapy. Primary objective is to collect information on acceptance rates and reasons for refusal of the proposed strategies for ovarian function and/or fertility preservation available in Italy.Results
At the study coordinating center, 223 patients were recruited between November 2012 and Dec
SUBMITTER: Blondeaux E
PROVIDER: S-EPMC8210666 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature